{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:20:39Z","timestamp":1786123239611,"version":"build-2736575974"},"reference-count":96,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>\n                    Xenon and argon are currently being evaluated as potential neuroprotective treatments for acquired brain injuries. Xenon has been evaluated clinically as a treatment for brain ischemia with equivocal results in small trials, but argon has not yet undergone clinical evaluation. Several preclinical studies have investigated xenon or argon as treatments in animal models of perinatal hypoxic-ischemic encephalopathy (HIE). A systematic review of MEDLINE and Embase databases was performed. After screening of titles, abstracts, and full text, data were extracted from included studies. A pairwise meta-analysis of neuroprotective efficacy was performed using a random effects model. Heterogeneity was investigated using subgroup analysis, funnel plot asymmetry, and Egger\u2019s regression. The protocol was prospectively registered on PROSPERO (CRD42022301986). A total of 21 studies met the inclusion criteria. The data extracted included measurements from 1591 animals, involving models of HIE in mice, rats, and pigs. The meta-analysis found that both xenon and argon had significant (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; .0001) neuroprotective efficacies. The summary estimate for xenon was 39.7% (95% confidence interval [CI], 28.3%\u201351.1%) and for argon it was 70.3% (95% CI, 59.0%\u201381.7%). The summary effect for argon was significantly (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; .001) greater than that of xenon. Our results provide evidence supporting further investigation of xenon and argon as neuroprotective treatments for HIE.\n                  <\/jats:p>","DOI":"10.1213\/ane.0000000000007223","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T13:01:53Z","timestamp":1729861313000},"page":"327-342","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Xenon and Argon as Neuroprotective Treatments for Perinatal Hypoxic-Ischemic Brain Injury: A Preclinical Systematic Review and Meta-Analysis"],"prefix":"10.1213","volume":"141","author":[{"given":"Mariana","family":"Barros","sequence":"first","affiliation":[{"name":"Anaesthetics, Pain Medicine and Intensive Care Division, Department of Surgery and Cancer, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liang","sequence":"additional","affiliation":[{"name":"Anaesthesiology Research Institute, Department of Anaesthesiology, First Affiliated Hospital of Fujian Medical University, Binhai Campus, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Iannucci","sequence":"additional","affiliation":[{"name":"Anaesthetics, Pain Medicine and Intensive Care Division, Department of Surgery and Cancer, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dickinson","sequence":"additional","affiliation":[{"name":"Anaesthetics, Pain Medicine and Intensive Care Division, Department of Surgery and Cancer, Imperial College London, London, United Kingdom"},{"name":"Centre for Blast Injury Studies, Imperial College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"R1-20250714","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(14)61698-6","article-title":"Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis.","volume":"385","author":"Liu","year":"2015","journal-title":"Lancet"},{"key":"R2-20250714","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","article-title":"Epidemiology of neonatal encephalopathy and hypoxic\u2013ischaemic encephalopathy.","volume":"86","author":"Kurinczuk","year":"2010","journal-title":"Early Hum Dev"},{"key":"R3-20250714","first-page":"S379","article-title":"Perinatal hypoxic-ischemic damage: review of the current treatment possibilities.","volume":"69","author":"Frajewicki","year":"2020","journal-title":"Physiol Res"},{"key":"R4-20250714","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1542\/peds.100.6.1004","article-title":"Interventions for perinatal hypoxic-ischemic encephalopathy.","volume":"100","author":"Vannucci","year":"1997","journal-title":"Pediatrics"},{"key":"R5-20250714","doi-asserted-by":"crossref","first-page":"c363","DOI":"10.1136\/bmj.c363","article-title":"Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data.","volume":"340","author":"Edwards","year":"2010","journal-title":"Bmj"},{"key":"R6-20250714","doi-asserted-by":"crossref","first-page":"F380","DOI":"10.1136\/adc.2004.067520","article-title":"Neuropsychological and educational problems at school age associated with neonatal encephalopathy.","volume":"90","author":"Marlow","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R7-20250714","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00431-007-0437-8","article-title":"Long-term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: a review.","volume":"166","author":"van Handel","year":"2007","journal-title":"Eur J Pediatr"},{"key":"R8-20250714","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/B978-0-444-64029-1.00010-2","article-title":"Neonatal encephalopathy and hypoxic-ischemic encephalopathy.","volume":"162","author":"Gunn","year":"2019","journal-title":"Handb Clin Neurol"},{"key":"R9-20250714","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa0900854","article-title":"Moderate hypothermia to treat perinatal asphyxial encephalopathy.","volume":"361","author":"Azzopardi","year":"2009","journal-title":"N Engl J Med"},{"key":"R10-20250714","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archpediatrics.2011.1772","article-title":"Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis.","volume":"166","author":"Tagin","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R11-20250714","first-page":"CD003311","article-title":"Cooling for newborns with hypoxic ischaemic encephalopathy.","volume":"2013","author":"Jacobs","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R12-20250714","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/00000542-200004000-00024","article-title":"Contrasting synaptic actions of the inhalational general anesthetics isoflurane and xenon.","volume":"92","author":"de Sousa","year":"2000","journal-title":"Anesthesiology"},{"key":"R13-20250714","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/24525","article-title":"How does xenon produce anaesthesia?","volume":"396","author":"Franks","year":"1998","journal-title":"Nature"},{"key":"R14-20250714","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1124\/mol.65.2.443","article-title":"Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane.","volume":"65","author":"Gruss","year":"2004","journal-title":"Mol Pharmacol"},{"key":"R15-20250714","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00000542-200402000-00025","article-title":"Determinants of the sensitivity of AMPA receptors to xenon.","volume":"100","author":"Plested","year":"2004","journal-title":"Anesthesiology"},{"key":"R16-20250714","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/ALN.0b013e31819dadc7","article-title":"Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels.","volume":"110","author":"Bantel","year":"2009","journal-title":"Anesthesiology"},{"key":"R17-20250714","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejphar.2011.10.045","article-title":"The noble gas argon modifies extracellular signal-regulated kinase 1\/2 signaling in neurons and glial cells.","volume":"674","author":"Fahlenkamp","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"R18-20250714","doi-asserted-by":"crossref","first-page":"1225191","DOI":"10.3389\/fnins.2023.1225191","article-title":"The cellular mechanisms associated with the anesthetic and neuroprotective properties of xenon: a systematic review of the preclinical literature.","volume":"17","author":"McGuigan","year":"2023","journal-title":"Front Neurosci"},{"key":"R19-20250714","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/cc9051","article-title":"Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection.","volume":"14","author":"Dickinson","year":"2010","journal-title":"Crit Care"},{"key":"R20-20250714","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bja.2017.10.017","article-title":"Moving to human trials for argon neuroprotection in neurological injury: a narrative review.","volume":"120","author":"Gardner","year":"2018","journal-title":"Br J Anaesth"},{"key":"R21-20250714","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40635-020-0294-6","article-title":"Update of the organoprotective properties of xenon and argon: from bench to beside.","volume":"8","author":"Roehl","year":"2020","journal-title":"Intensive Care Med Exp"},{"key":"R22-20250714","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s12630-015-0507-8","article-title":"Preclinical neuroprotective actions of xenon and possible implications for human therapeutics: a narrative review.","volume":"63","author":"Maze","year":"2016","journal-title":"Can J Anaesth"},{"key":"R23-20250714","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12035-019-01761-z","article-title":"Neuroprotective properties of xenon.","volume":"57","author":"Maze","year":"2020","journal-title":"Mol Neurobiol"},{"key":"R24-20250714","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/ALN.0b013e3182a2a265","article-title":"Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site.","volume":"119","author":"Harris","year":"2013","journal-title":"Anesthesiology"},{"key":"R25-20250714","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bja.2019.07.010","article-title":"Noble gas neuroprotection: xenon and argon protect against hypoxic-ischaemic injury in rat hippocampus in vitro via distinct mechanisms.","volume":"123","author":"Koziakova","year":"2019","journal-title":"Br J Anaesth"},{"key":"R26-20250714","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/ALN.0b013e3181cea398","article-title":"Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia.","volume":"112","author":"Banks","year":"2010","journal-title":"Anesthesiology"},{"key":"R27-20250714","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1097\/CCM.0000000000003809","article-title":"Argon inhalation for 24 hours after onset of permanent focal cerebral ischemia in rats provides neuroprotection and improves neurologic outcome.","volume":"47","author":"Ma","year":"2019","journal-title":"Crit Care Med"},{"key":"R28-20250714","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/CCM.0b013e31821209be","article-title":"Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats.","volume":"39","author":"Ryang","year":"2011","journal-title":"Crit Care Med"},{"key":"R29-20250714","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bja.2020.08.027","article-title":"Efficacy of inhaled argon administered acutely after traumatic brain injury in mice.","volume":"126","author":"Moro","year":"2021","journal-title":"Br J Anaesth"},{"key":"R30-20250714","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/SHK.0000000000000049","article-title":"Postresuscitation treatment with argon improves early neurological recovery in a porcine model of cardiac arrest.","volume":"41","author":"Ristagno","year":"2014","journal-title":"Shock"},{"key":"R31-20250714","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13054-019-2493-7","article-title":"Post-stroke treatment with argon attenuated brain injury, reduced brain inflammation and enhanced M2 microglia\/macrophage polarization: a randomized controlled animal study.","volume":"23","author":"Liu","year":"2019","journal-title":"Crit Care"},{"key":"R32-20250714","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2015.12.001","article-title":"Inhaled 45-50% argon augments hypothermic brain protection in a piglet model of perinatal asphyxia.","volume":"87","author":"Broad","year":"2016","journal-title":"Neurobiol Dis"},{"key":"R33-20250714","doi-asserted-by":"crossref","first-page":"25640","DOI":"10.18632\/oncotarget.8241","article-title":"Argon protects against hypoxic-ischemic brain injury in neonatal rats through activation of nuclear factor (erythroid-derived 2)-like 2.","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"R34-20250714","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/ALN.0000000000001128","article-title":"Heme oxygenase-1 mediates neuroprotection conferred by argon in combination with hypothermia in neonatal hypoxia-ischemia brain injury.","volume":"125","author":"Zhao","year":"2016","journal-title":"Anesthesiology"},{"key":"R35-20250714","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bja.2022.04.016","article-title":"Neuroprotection by the noble gases argon and xenon as treatments for acquired brain injury: a preclinical systematic review and meta-analysis.","volume":"129","author":"Liang","year":"2022","journal-title":"Br J Anaesth"},{"key":"R36-20250714","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1242\/jeb.01064","article-title":"Hypoxia\u2013ischemia in the immature brain.","volume":"207","author":"Vannucci","year":"2004","journal-title":"J Exp Biol"},{"key":"R37-20250714","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fncel.2017.00078","article-title":"Neonatal hypoxia ischaemia: mechanisms, models, and therapeutic challenges.","volume":"11","author":"Millar","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"R38-20250714","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/cercor\/bht246","article-title":"Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain.","volume":"25","author":"Jantzie","year":"2015","journal-title":"Cereb Cortex"},{"key":"R39-20250714","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1523\/JNEUROSCI.18-16-06241.1998","article-title":"Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion.","volume":"18","author":"Back","year":"1998","journal-title":"J Neurosci"},{"key":"R40-20250714","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1523\/JNEUROSCI.21-04-01302.2001","article-title":"Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury.","volume":"21","author":"Back","year":"2001","journal-title":"J Neurosci"},{"key":"R41-20250714","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1203\/00006450-200106000-00003","article-title":"Neurobiology of hypoxic-ischemic injury in the developing brain.","volume":"49","author":"Johnston","year":"2001","journal-title":"Pediatr Res"},{"key":"R42-20250714","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1523\/JNEUROSCI.20-21-07994.2000","article-title":"Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat.","volume":"20","author":"Nakajima","year":"2000","journal-title":"J Neurosci"},{"key":"R43-20250714","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-510X(98)00036-7","article-title":"Intact, injured, necrotic and apoptotic cells after focal cerebral ischemia in the rat.","volume":"156","author":"Li","year":"1998","journal-title":"J Neurol Sci"},{"key":"R44-20250714","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1203\/00006450-199705000-00002","article-title":"The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat.","volume":"41","author":"Hudome","year":"1997","journal-title":"Pediatr Res"},{"key":"R45-20250714","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrneurol.2015.13","article-title":"The role of inflammation in perinatal brain injury.","volume":"11","author":"Hagberg","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"R46-20250714","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ana.20547","article-title":"Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia.","volume":"58","author":"Ma","year":"2005","journal-title":"Ann Neurol"},{"key":"R47-20250714","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bja.2019.02.032","article-title":"Xenon improves long-term cognitive function, reduces neuronal loss and chronic neuroinflammation, and improves survival after traumatic brain injury in mice.","volume":"123","author":"Campos-Pires","year":"2019","journal-title":"Br J Anaesth"},{"key":"R48-20250714","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s13054-020-03373-9","article-title":"Xenon treatment after severe traumatic brain injury improves locomotor outcome, reduces acute neuronal loss and enhances early beneficial neuroinflammation: a randomized, blinded, controlled animal study.","volume":"24","author":"Campos-Pires","year":"2020","journal-title":"Crit Care"},{"key":"R49-20250714","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ebm2.7","article-title":"A protocol format for the preparation, registration and publication of systematic reviews of animal intervention studies.","volume":"2","author":"de Vries","year":"2015","journal-title":"Evidence-based Preclinl Med"},{"key":"R50-20250714","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ilar\/ilu042","article-title":"Meta-analyses of animal studies: an introduction of a valuable instrument to further improve healthcare.","volume":"55","author":"Hooijmans","year":"2014","journal-title":"ILAR J"},{"key":"R51-20250714","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneumeth.2013.09.010","article-title":"Meta-analysis of data from animal studies: a practical guide.","volume":"221","author":"Vesterinen","year":"2014","journal-title":"J Neurosci Methods"},{"key":"R52-20250714","doi-asserted-by":"crossref","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"key":"R53-20250714","doi-asserted-by":"crossref","first-page":"A12","DOI":"10.7326\/ACPJC-1995-123-3-A12","article-title":"The well-built clinical question: a key to evidence-based decisions.","volume":"123","author":"Richardson","year":"1995","journal-title":"ACP J Club"},{"key":"R54-20250714","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/01.STR.0000125719.25853.20","article-title":"Pooling of animal experimental data reveals influence of study design and publication bias.","volume":"35","author":"Macleod","year":"2004","journal-title":"Stroke"},{"key":"R55-20250714","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tins.2007.06.009","article-title":"How can we improve the pre-clinical development of drugs for stroke?","volume":"30","author":"Sena","year":"2007","journal-title":"Trends Neurosci"},{"key":"R56-20250714","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","article-title":"Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness.","volume":"13","author":"Tufanaru","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"R57-20250714","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis.","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"R58-20250714","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"Bmj"},{"key":"R59-20250714","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ana.22016","article-title":"Xenon enhances hypothermic neuroprotection in asphyxiated newborn pigs.","volume":"68","author":"Chakkarapani","year":"2010","journal-title":"Ann Neurol"},{"key":"R60-20250714","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/01.STR.0000198867.31134.ac","article-title":"Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia.","volume":"37","author":"Dingley","year":"2006","journal-title":"Stroke"},{"key":"R61-20250714","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.22387","article-title":"Xenon augmented hypothermia reduces early lactate\/N-acetylaspartate and cell death in perinatal asphyxia.","volume":"70","author":"Faulkner","year":"2011","journal-title":"Ann Neurol"},{"key":"R62-20250714","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/STROKEAHA.107.499822","article-title":"Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia\/ischemia.","volume":"39","author":"Hobbs","year":"2008","journal-title":"Stroke"},{"key":"R63-20250714","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/pr.2015.49","article-title":"Adding 5 h delayed xenon to delayed hypothermia treatment improves long-term function in neonatal rats surviving to adulthood.","volume":"77","author":"Liu","year":"2015","journal-title":"Pediatr Res"},{"key":"R64-20250714","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/ALN.0b013e3181895f88","article-title":"Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model.","volume":"109","author":"Luo","year":"2008","journal-title":"Anesthesiology"},{"key":"R65-20250714","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.jcbfm.9600184","article-title":"Xenon preconditioning reduces brain damage from neonatal asphyxia in rats.","volume":"26","author":"Ma","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"R66-20250714","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/bja\/ael340","article-title":"Asynchronous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat.","volume":"98","author":"Martin","year":"2007","journal-title":"Br J Anaesth"},{"key":"R67-20250714","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neulet.2006.09.020","article-title":"Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models.","volume":"409","author":"Rajakumaraswamy","year":"2006","journal-title":"Neurosci Lett"},{"key":"R68-20250714","doi-asserted-by":"crossref","first-page":"e109845","DOI":"10.1371\/journal.pone.0109845","article-title":"Combined treatment of xenon and hypothermia in newborn rats\u2014additive or synergistic effect?","volume":"9","author":"Sabir","year":"2014","journal-title":"PLoS One"},{"key":"R69-20250714","doi-asserted-by":"crossref","first-page":"e0156759","DOI":"10.1371\/journal.pone.0156759","article-title":"Xenon combined with therapeutic hypothermia is not neuroprotective after severe hypoxia-ischemia in neonatal rats.","volume":"11","author":"Sabir","year":"2016","journal-title":"PLoS One"},{"key":"R70-20250714","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/WNR.0000000000001888","article-title":"Xenon attenuates hypoxic-ischemic brain damage by inhibiting autophagy in neonatal rats.","volume":"34","author":"Sun","year":"2023","journal-title":"Neuroreport"},{"key":"R71-20250714","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/jcbfm.2008.163","article-title":"Cooling combined with immediate or delayed xenon inhalation provides equivalent long-term neuroprotection after neonatal hypoxia-ischemia.","volume":"29","author":"Thoresen","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"R72-20250714","doi-asserted-by":"crossref","first-page":"e37020","DOI":"10.1371\/journal.pone.0037020","article-title":"Xenon and Sevoflurane Provide Analgesia during Labor and Fetal Brain Protection in a Perinatal Rat Model of Hypoxia-Ischemia.","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS ONE"},{"key":"R73-20250714","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.freeradbiomed.2020.09.030","article-title":"Attenuation of the mutual elevation of iron accumulation and oxidative stress may contribute to the neuroprotective and anti-seizure effects of xenon in neonatal hypoxia-induced seizures.","volume":"161","author":"Zhang","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"R74-20250714","doi-asserted-by":"crossref","first-page":"113054","DOI":"10.1016\/j.expneurol.2019.113054","article-title":"Xenon exerts anti-seizure and neuroprotective effects in kainic acid-induced status epilepticus and neonatal hypoxia-induced seizure.","volume":"322","author":"Zhang","year":"2019","journal-title":"Exp Neurol"},{"key":"R75-20250714","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1097\/CCM.0b013e3182452164","article-title":"The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats.","volume":"40","author":"Zhuang","year":"2012","journal-title":"Crit Care Med"},{"key":"R76-20250714","doi-asserted-by":"crossref","first-page":"1028688","DOI":"10.3389\/fphar.2022.1028688","article-title":"Noble gas and neuroprotection: From bench to bedside.","volume":"13","author":"Yin","year":"2022","journal-title":"Front Pharmacol"},{"key":"R77-20250714","doi-asserted-by":"crossref","first-page":"18175","DOI":"10.3390\/ijms151018175","article-title":"Argon: systematic review on neuro- and organoprotective properties of an \u201cinert\u201d gas.","volume":"15","author":"Hollig","year":"2014","journal-title":"Int J Mol Sci"},{"key":"R78-20250714","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/aca.ACA_111_18","article-title":"A complete review of preclinical and clinical uses of the noble gas argon: evidence of safety and protection.","volume":"22","author":"Nespoli","year":"2019","journal-title":"Ann Card Anaesth"},{"key":"R79-20250714","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pediatrneurol.2018.02.009","article-title":"Xenon combined with hypothermia in perinatal hypoxic-ischemic encephalopathy: a noble gas, a noble mission.","volume":"84","author":"Amer","year":"2018","journal-title":"Pediatr Neurol"},{"key":"R80-20250714","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jnr.23178","article-title":"Hypothermia and xenon: novel noble guardians in hypoxic-ischemic encephalopathy?","volume":"91","author":"Lobo","year":"2013","journal-title":"J Neurosci Res"},{"key":"R81-20250714","doi-asserted-by":"crossref","first-page":"22368","DOI":"10.3390\/ijms160922368","article-title":"Neuroprotective strategies after neonatal hypoxic ischemic encephalopathy.","volume":"16","author":"Dixon","year":"2015","journal-title":"Int J Mol Sci"},{"key":"R82-20250714","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.freeradbiomed.2019.04.028","article-title":"Novel interventions to reduce oxidative-stress related brain injury in neonatal asphyxia.","volume":"142","author":"Solevag","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"R83-20250714","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clp.2019.02.006","article-title":"Pharmacologic prevention and treatment of neonatal brain injury.","volume":"46","author":"McNally","year":"2019","journal-title":"Clin Perinatol"},{"key":"R84-20250714","doi-asserted-by":"crossref","first-page":"e886","DOI":"10.1097\/CCM.0000000000001717","article-title":"The efficacy of noble gases in the attenuation of ischemia reperfusion injury: a systematic review and meta-analyses.","volume":"44","author":"De Deken","year":"2016","journal-title":"Crit Care Med"},{"key":"R85-20250714","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bja.2018.07.024","article-title":"Neuroprotection by anaesthetics in rodent models of traumatic brain injury: a systematic review and network meta-analysis.","volume":"121","author":"Archer","year":"2018","journal-title":"Br J Anaesth"},{"key":"R86-20250714","doi-asserted-by":"crossref","first-page":"e100074","DOI":"10.1136\/bmjos-2020-100074","article-title":"Comparison of commonly used methods in random effects meta-analysis: application to preclinical data in drug discovery research.","volume":"5","author":"Tanriver-Ayder","year":"2021","journal-title":"BMJ Open Sci"},{"key":"R87-20250714","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12874-015-0024-z","article-title":"The heterogeneity statistic I(2) can be biased in small meta-analyses.","volume":"15","author":"von Hippel","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"R88-20250714","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.","volume":"343","author":"Sterne","year":"2011","journal-title":"Bmj"},{"key":"R89-20250714","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1161\/01.STR.30.12.2752","article-title":"Recommendations for standards regarding preclinical neuroprotective and restorative drug development.","volume":"30","year":"1999","journal-title":"Stroke"},{"key":"R90-20250714","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1161\/01.STR.0000025518.34157.51","article-title":"Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions.","volume":"33","author":"Gladstone","year":"2002","journal-title":"Stroke"},{"key":"R91-20250714","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/jamaneurol.2013.6299","article-title":"Importance of preclinical research in the development of neuroprotective strategies for ischemic stroke.","volume":"71","author":"Neuhaus","year":"2014","journal-title":"JAMA Neurol"},{"key":"R92-20250714","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(15)00347-6","article-title":"Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial.","volume":"15","author":"Azzopardi","year":"2016","journal-title":"Lancet Neurol"},{"key":"R93-20250714","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jama.2016.1933","article-title":"Effect of inhaled xenon on cerebral white matter damage in comatose survivors of out-of-hospital cardiac arrest: a randomized clinical trial.","volume":"315","author":"Laitio","year":"2016","journal-title":"JAMA"},{"key":"R94-20250714","article-title":"Neuroprotective effects of inhaled xenon gas on brain structural gray matter changes after out-of-hospital cardiac arrest evaluated by morphometric analysis: a substudy of the randomized xe-hypotheca trial.","author":"Hollmen","year":"2024","journal-title":"Neurocrit Care"},{"key":"R95-20250714","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ebiom.2019.08.034","article-title":"Prospective qualification of early cerebral biomarkers in a randomised trial of treatment with xenon combined with moderate hypothermia after birth asphyxia.","volume":"47","author":"Azzopardi","year":"2019","journal-title":"EBioMedicine"},{"key":"R96-20250714","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/CCM.0000000000000624","article-title":"Xenon improves neurologic outcome and reduces secondary injury following trauma in an in vivo model of traumatic brain injury.","volume":"43","author":"Campos-Pires","year":"2015","journal-title":"Crit Care Med"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:28:45Z","timestamp":1786112925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000007223","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]}}}